Femasys Inc (FEMY) stock
FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/3072% below fair value
$1.42+0.02 (+1.43%)
Close on Nov 13, 2026Market cap $11.89MP/E –Yield –
Femasys total assets
Total assets on the balance sheet at the end of each period.
Femasys's total assets was $35.09M at Sep 30, 2026. For fiscal 2025 it was $20.72M, up 66.5% from the year before. The highest annual figure on record is $28.58M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.72M | +66.5% |
| FY2024 | Dec 31, 2024 | $12.45M | -55.2% |
| FY2023 | Dec 31, 2023 | $27.76M | +64.3% |
| FY2022 | Dec 31, 2022 | $16.90M | -40.9% |
| FY2021 | Dec 31, 2021 | $28.58M | +275.7% |
| FY2020 | Dec 31, 2020 | $7.61M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $35.09M | +115.4% |
| Q2 FY2026 | Jun 30, 2026 | $12.29M | -10.8% |
| Q1 FY2026 | Mar 31, 2026 | $16.50M | +24.2% |
| Q4 FY2025 | Dec 31, 2025 | $20.72M | +66.5% |
| Q3 FY2025 | Sep 30, 2025 | $16.29M | +4.5% |
| Q2 FY2025 | Jun 30, 2025 | $13.78M | -32.0% |
| Q1 FY2025 | Mar 31, 2025 | $13.28M | -45.5% |
| Q4 FY2024 | Dec 31, 2024 | $12.45M | -55.2% |
| Q3 FY2024 | Sep 30, 2024 | $15.59M | +4.9% |
| Q2 FY2024 | Jun 30, 2024 | $20.28M | +41.7% |
| Q1 FY2024 | Mar 31, 2024 | $24.37M | +75.7% |
| Q4 FY2023 | Dec 31, 2023 | $27.76M | +64.3% |
| Q3 FY2023 | Sep 30, 2023 | $14.85M | -25.9% |
| Q2 FY2023 | Jun 30, 2023 | $14.31M | -38.1% |
| Q1 FY2023 | Mar 31, 2023 | $13.87M | -45.7% |
| Q4 FY2022 | Dec 31, 2022 | $16.90M | -40.9% |
| Q3 FY2022 | Sep 30, 2022 | $20.03M | -35.7% |
| Q2 FY2022 | Jun 30, 2022 | $23.12M | -32.0% |
| Q1 FY2022 | Mar 31, 2022 | $25.53M | +235.7% |
| Q4 FY2021 | Dec 31, 2021 | $28.58M | – |
| Q3 FY2021 | Sep 30, 2021 | $31.16M | – |
| Q2 FY2021 | Jun 30, 2021 | $33.99M | – |
| Q4 FY2020 | Dec 31, 2020 | $7.61M | – |
See a number that looks wrong?